Carmela C.

Carmela C. is an experienced professional in clinical operations and research, currently serving as Head of US Clinical Operations at Amber Therapeutics since October 2024. Prior to this role, Carmela C. worked as a consultant at Avania from January 2023 to October 2024 and held the position of VP, Clinical Affairs (US) at Occlutech from 2021 to November 2022. Additional experience includes roles as Clinical Program Manager at Abiomed and Terumo Medical Corporation, and Clinical Subjects Coordinator at the University of Michigan Health System. Carmela C. began a career in the field with positions at PDL BioPharma, I. Brodsky Associates, Theravance Biopharma US, Inc., and the Office of Statewide Health Planning and Development. Educational qualifications include a Master of Science degree from Drexel University College of Medicine and a Bachelor of Science degree from the University of California, Davis.